Yarrow Bioscience (YARW) Price to Sales (2018 - 2026)

Yarrow Bioscience (YARW) has reported Price to Sales for 9 consecutive years, with 279.28 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 60.42% year-over-year to 279.28; the trailing twelve-month figure through Jun 2026 stood at 55.63 (down 60.02% YoY), and the FY2025 full-year result was 41.34, down 85.48% from the prior year.
• Price to Sales advanced to 279.28 in Q2 2026 per YARW's latest filing, from 255.75 in the prior quarter.
• Across five years, Price to Sales topped out at 3806.35 in Q1 2022 and bottomed at 99.69 in Q2 2023.
• Historically, Price to Sales has averaged 938.7 across 5 years, with a median of 376.63 in 2024.
• The sharpest annual moves came in 2023 and 2024: Price to Sales sank 97.35% in 2023, then soared 1197.43% in 2024.
• Over 5 years, Price to Sales stood at 300.7 in 2022, then advanced by 4.74% to 314.95 in 2023, then surged by 439.29% to 1698.49 in 2024, then tumbled by 58.46% to 705.52 in 2025, then plunged by 60.42% to 279.28 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 279.28, 255.75, and 705.52 for Q2 2026, Q1 2026, and Q2 2025 respectively.